Merck KGaA shares slump after Erbitux rejection
July 24, 2009 at 06:22 AM EDT
Shares in German drug and chemicals group Merck KGaA drop as after European authorities unexpectedly reject its Erbitux cancer drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.